India’s Lorlatinib 100mg ALK/ROS1 mNSCLC Advanced Treatment

This is a new ALK and ROS1 inhibitor, kind of like a, used for metastatic lung cancer with ALK when other ALK blockers have stopped working. This medication targets a specific part of cancer cells, specifically the ALK and ROS1 kinases that make the cancer grow. The pill comes in both 25 mg and 100 mg dosages, and you take it as a coated tablet.

The usual adult dose for this lung cancer is 100 mg, taken once each day. You can take it with food or on an empty stomach. Each pack comes with a bottle that’s got 30 pills in it.